Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...

OmniChicken yields many monoclonal antibodies (mAbs) that recognize both the human and murine antigen and therefore obviates the use of surrogate antibodies in preclinical studies. In many ...

The recent advancements in the TATX-112 program have led to the discovery of multiple antibodies that can infiltrate and eliminate TrkB-expressing cells in an in vitro surrogate Antibody Drug ...